It has been widely reported that depression is associated with a downregulation of brain BDNF levels (Brunoni et al., 2008; Lee and Kim, 2010) being regarded as a major target of antidepressant medications (Chen et al., 2001). This evidence concerns the gene BDNF and depressive symptom measurement.